{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/139291403"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "roved by the U.S. Food and Drug Administration for the single-agent treatment of metastatic renal cell cancer, can also cause symptoms such as fatigue, nausea, vomiting, and diarrhea.[18,19] Response to interleukin-2 treatment varies; some patients gain weight, and some require nutritional support.[19] However, most patients taking interleukin gain weight." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "concordhospital.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/428917439"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/139291403"] } } }
